Discover
ETNB
89bio, Inc.
14.84
19 x 14.82
1 x 14.86
bid
ask
+
14.84
0.00%
07:00 PM
| Ytd | 89.77% | |
| 1y | 85.73% |
day range
52 week range
| Open | Prev Close | Low | High | Mkt Cap | N/A | ||||
| Vol | 0.00 | Avg Vol | 0.00 | EPS | N/A | P/E | N/A | Forward P/E | -5.17 |
| Beta | 1.26 | Short Ratio | 0.74 | Inst. Own | 103.69% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | N/A | 200-d Avg | N/A | 1yr Est | 30.38 |
| Income Statement | |||
| Operating Expenses | 115.82M | ||
| Research and Development Expense | 103.90M | ||
| Selling, General and Administrative Expense | 11.92M | ||
| Operating Income | -115.82M | ||
| Interest Expense | 1.14M | ||
| Income Tax Expense | 753.00K | ||
| Net Income | -111.50M | ||
| Net Income Common Stock | -111.50M | ||
| Net Income Common Stock (USD) | -111.50M | ||
| Consolidated Income | -111.50M | ||
| Earnings per Basic Share | -0.71 | ||
| Earnings per Basic Share (USD) | -0.71 | ||
| Earnings per Diluted Share | -0.71 | ||
| Earning Before Interest & Taxes (EBIT) | -109.61M | ||
| Earning Before Interest & Taxes (USD) | -109.61M | ||
| Weighted Average Shares | 157.88M | ||
| Weighted Average Shares Diluted | 157.88M | ||
| Balance Sheet | |||
| Cash and Equivalents | 129.08M | ||
| Cash and Equivalents (USD) | 129.08M | ||
| Investments | 432.09M | ||
| Investments Current | 432.09M | ||
| Current Assets | 601.52M | ||
| Property, Plant & Equipment Net | 1.33M | ||
| Total Assets | 603.49M | ||
| Debt Current | 784.00K | ||
| Total Debt | 37.62M | ||
| Current Liabilities | 39.61M | ||
| Debt Non-Current | 36.84M | ||
| Total Liabilities | 81.75M | ||
| Accumulated Retained Earnings (Deficit) | -1.01B | ||
| Accumulated Other Comprehensive Income | 122.00K | ||
| Shareholders Equity | 521.73M | ||
| Shareholders Equity (USD) | 521.73M | ||
| Assets Non-Current | 1.97M | ||
| Total Debt (USD) | 37.62M | ||
| Liabilities Non-Current | 42.14M | ||
| Trade and Non-Trade Payables | 14.66M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 161.00K | ||
| Net Cash Flow from Financing | 20.73M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -186.32M | ||
| Issuance (Purchase) of Equity Shares | 21.30M | ||
| Net Cash Flow from Investing | -106.62M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -106.62M | ||
| Net Cash Flow from Operations | -100.42M | ||
| Share Based Compensation | 7.32M | ||